Qiagen N.V. (FRA:QIA)

Market Cap	8.50B -6.5%
Revenue (ttm)	1.78B +5.7%
Net Income	361.87M +408.3%
EPS	1.74 +409.8%
Shares Out	n/a
PE Ratio	23.48
Forward PE	18.80
Dividend	2.18 (5.10%)
Ex-Dividend Date	Jan 8, 2026

Volume	933
Average Volume	1,059
Open	40.60
Previous Close	41.33
Day's Range	40.60 - 41.46
52-Week Range	34.21 - 48.80
Beta	n/a
RSI	39.03
Earnings Date	Feb 4, 2026

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,654
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QIA

Financial Performance

In 2025, Qiagen's revenue was $2.09 billion, an increase of 5.65% compared to the previous year's $1.98 billion. Earnings were $424.88 million, an increase of 408.28%.

Financial numbers in USD